Overview

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
A multicentre, randomized, open-label, parallel-group, active controlled study.
Phase:
Phase 2
Details
Lead Sponsor:
Hunan Provincial People's Hospital
Treatments:
Arsenic Trioxide